|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 14, Issue 4, 1392-1404, April 2003


§ and
*Dipartimento di Istologia ed Embriologia Medica,
Università di Roma La Sapienza, 00161 Roma, Italia;
Inhibition of type 4 cAMP-specific phosphodiesterase (PDE4)
activity in L6-C5 and L6-E9 abolished myogenic differentiation induced
by low-serum medium and IGF-I. L6-C5 cells cultured in low-serum medium
displayed a PDE4 activity higher than cells cultured in serum-free
medium, a condition not sufficient to induce differentiation. In the
presence of serum, PDE4D3, the major isoform natively expressed in
L6-C5 cells, translocated to a Triton-insoluble fraction, which increased the PDE specific activity of the fraction, and exhibited a Mr
shift typical of phosphorylation of this isoform. Furthermore, serum
promoted the localization of PDE4D3 to a vesicular subcellular compartment. In L6-C5 cells, IGF-I is a stronger inducer of myogenic differentiation in the presence than in absence of serum. Its ability
to trigger differentiation in the absence of serum was restored by
overexpressing wild-type PDE4D3, but not a phosphorylation-insensitive mutant. This finding was confirmed in single cells overexpressing a
GFP-PDE4D3 fusion protein by assessing nuclear accumulation of myogenin
in both L6-C5 and L6-E9. Overexpression of other PDE isoforms was less
efficient, confirming that PDE4D3 is the physiologically relevant
phosphodiesterase isoform in the control of myogenesis. These results
show that downregulation of cAMP signaling through cAMP-phosphodiesterase stimulation is a prerequisite for induction of myogenesis.
INSERM U352, Laboratoire de Biochimie et
Pharmacologie, INSA de Lyon, 69621, Villeurbanne France; and
Division of Reproductive Biology, Stanford
University School of Medicine, Stanford, California 94305-5317
This article has been cited by other articles:
![]() |
F. Naro, V. De Arcangelis, C. Sette, C. Ambrosio, H. Komati, M. Molinaro, S. Adamo, and G. Nemoz A Bimodal Modulation of the cAMP Pathway Is Involved in the Control of Myogenic Differentiation in L6 Cells J. Biol. Chem., December 5, 2003; 278(49): 49308 - 49315. [Abstract] [Full Text] [PDF] |
||||